Université de Bordeaux

• European Commission

  HORIZON-TMA-MSCA-DN, CDT-net: The Cardiovascular Digital Twin Network, 101312147, €314.7k, 2026–2030, 8 Jul 2026

• European Commission

  HORIZON-TMA-MSCA-SE, CliCBrain: Climate, Cities and Brain health; Addressing the impact of climate and exposome on brain health, 101236426, €170.3k, 2026–2029, 24 Sept 2025

• European Commission

  HORIZON-JU-RIA, Toxicity of dolutegravir and evaluation of doravirine for alternative 1st line antiretroviral treatment in people living with HIV, 101190925, €1.5m, 2025–2029, Lead, 19 May 2025

• European Commission

  HORIZON-RIA, Dissecting Brain Pollutant Exposure and its Contribution to Neurodegeneration and Alzheimer’s disease: From Signatures to Prevention Strategies to Protect and Maintain a Healthy Brain, 101156353, €1.4m, 2025–2029, 7 Nov 2024

• European Commission

  HORIZON-TMA-MSCA-DN, Effective Delivery of Nucleic Acid Therapeutics via Designed Nanocarriers, 101168881, €565.4k, 2024–2028, 10 Jul 2024

Sources: cordis.europa.eu

• Plasma Vitamin D and Intermediate Age-Related Macular Degeneration: Insights from the Longitudinal ALIENOR Study

  17 Aug 2026

• Re-evaluating CD57 as a marker of T cell senescence: implications for immune ageing and differentiation

  Senior IdEx Chair, 31 Oct 2025

Sources: api.crossref.org